Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Needham cut ON Semiconductor Corporation ON price target from $57 to $50. Needham analyst Quinn Bolton maintained a Buy rating. ON Semiconductor shares closed at $38.41 on Monday. See how other analysts view this stock.
Compass Point slashed the price target for MARA Holdings, Inc. MARA from $25 to $9.5. Compass Point analyst Joe Flynn downgraded the stock from Neutral to Sell. MARA Holdings shares closed at $13.09 on Monday. See how other analysts view this stock.
Leerink Partners cut Vertex Pharmaceuticals Incorporated VRTX price target from $550 to $503. Leerink Partners analyst David Risinger downgraded the stock from Outperform to Market Perform. Vertex Pharmaceuticals shares closed at $500.19 on Monday. See how other analysts view this stock.
HC Wainwright & Co. raised the price target for Solaris Resources Inc. SLSR from $10 to $11. HC Wainwright & Co. analyst Heiko Ihle maintained a Buy rating. Solaris Resources shares closed at $4.33 on Monday. See how other analysts view this stock.
Telsey Advisory Group slashed the price target for Ethan Allen Interiors Inc. ETD from $32 to $30. Telsey Advisory Group analyst Cristina Fernandez maintained a Market Perform rating. Ethan Allen Interiors shares closed at $29.13 on Monday. See how other analysts view this stock.
Rosenblatt raised Fabrinet FN price target from $230 to $250. Rosenblatt analyst Mike Genovese maintained a Buy rating. Fabrinet shares settled at $220.90 on Monday. See how other analysts view this stock.
Telsey Advisory Group cut NIKE, Inc NKE price target from $80 to $70. Telsey Advisory Group analyst Cristina Fernandez maintained a Market Perform rating. Nike shares closed at $57.35 on Monday. See how other analysts view this stock.
Canaccord Genuity cut Castle Biosciences, Inc. CSTL price target from $42 to $37. Canaccord Genuity analyst Kyle Mikson maintained a Buy rating. Castle Biosciences shares closed at $18.75 on Monday. See how other analysts view this stock.
JP Morgan cut the price target for Twist Bioscience Corporation TWST from $40 to $33. JP Morgan analyst Rachel Vatnsdal maintained an Underweight rating. Twist Bioscience shares settled at $35.93 on Monday. See how other analysts view this stock.
JP Morgan raised Quest Diagnostics Incorporated DGX price target from $180 to $190. JP Morgan analyst Lisa Gill maintained a Neutral rating. Quest Diagnostics shares closed at $177.57 on Monday. See how other analysts view this stock.